Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125507662 | 12550766 | 2 | F | 20160701 | 20160711 | 20160712 | 20160822 | PER | US-ASTRAZENECA-2016SE72945 | ASTRAZENECA | 23702.00 | DY | F | Y | 40.80000 | KG | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125507662 | 12550766 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 180/4.5, 2 PUFFS TWICE A DAY | 21929 | BID | |||||||||
| 125507662 | 12550766 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 180/4.5, 2 PUFFS TWICE A DAY | 21929 | BID | |||||||||
| 125507662 | 12550766 | 3 | C | COMBIVENT RESTIMATE INHALER | 2 | Respiratory (inhalation) | 20MCG 100MCG, EVERY DAY AND TAKES IT EVERY 4 HOURS | 0 | |||||||||||
| 125507662 | 12550766 | 4 | C | COMBIVENT RESTIMATE INHALER | 2 | Respiratory (inhalation) | 20MCG 100MCG, EVERY DAY AND TAKES IT EVERY 4 HOURS | 0 | |||||||||||
| 125507662 | 12550766 | 5 | C | ALBUTEROL INHALER | ALBUTEROL | 1 | Respiratory (inhalation) | 90, AS REQUIRED | 0 | ||||||||||
| 125507662 | 12550766 | 6 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 220 | 0 | ||||||||||
| 125507662 | 12550766 | 7 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 125507662 | 12550766 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 15MLS FOR 3 DAYS, AS REQUIRED | 0 | ||||||||||
| 125507662 | 12550766 | 9 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 15MLS FOR 3 DAYS, AS REQUIRED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125507662 | 12550766 | 1 | Asthma |
| 125507662 | 12550766 | 2 | Chronic obstructive pulmonary disease |
| 125507662 | 12550766 | 3 | Asthma |
| 125507662 | 12550766 | 4 | Chronic obstructive pulmonary disease |
| 125507662 | 12550766 | 5 | Supplementation therapy |
| 125507662 | 12550766 | 8 | Asthma |
| 125507662 | 12550766 | 9 | Pneumonitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125507662 | 12550766 | Body height decreased | |
| 125507662 | 12550766 | Condition aggravated | |
| 125507662 | 12550766 | Counterfeit drug administered | |
| 125507662 | 12550766 | Dehydration | |
| 125507662 | 12550766 | Device malfunction | |
| 125507662 | 12550766 | Dizziness | |
| 125507662 | 12550766 | Drug ineffective | |
| 125507662 | 12550766 | Emotional distress | |
| 125507662 | 12550766 | Immune system disorder | |
| 125507662 | 12550766 | Insomnia | |
| 125507662 | 12550766 | Intentional product misuse | |
| 125507662 | 12550766 | Lung disorder | |
| 125507662 | 12550766 | Malaise | |
| 125507662 | 12550766 | Rubber sensitivity | |
| 125507662 | 12550766 | Suspected counterfeit product | |
| 125507662 | 12550766 | Thirst | |
| 125507662 | 12550766 | Toxicity to various agents | |
| 125507662 | 12550766 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125507662 | 12550766 | 3 | 2004 | 0 | ||
| 125507662 | 12550766 | 4 | 2004 | 0 | ||
| 125507662 | 12550766 | 5 | 1982 | 0 | ||
| 125507662 | 12550766 | 8 | 1982 | 0 | ||
| 125507662 | 12550766 | 9 | 1982 | 0 |